BACKGROUND: The shortage in organ donation is a major limiting factor for patients with end-stage lung disease. Expanding the donor pool would be beneficial. We investigated the importance of geographic distance between the donor and recipient and hypothesized that it would not be a critical determinant of outcomes after lung transplantation. METHODS: We retrospectively reviewed the United Network for Organ Sharing lung transplant database from 2000 to 2005 to allow sufficient time for bronchiolitis obliterans syndrome (BOS) development. Allograft recipients were stratified by geographic distance from their donors (local, regional, and national) and had yearly follow-up. The primary end points were the development of BOS and 1-year and 3-year mortality. Posttransplant outcomes were compared using a multivariable Cox proportional hazard model. Kaplan-Meier curves were compared by log-rank test. RESULTS: Of 6,055 allograft recipients, donors were local in 59%, regional in 19.3%, and national in 21.7%. BOS-free survival did not differ by geographic distance. Geographic distance did not independently predict BOS (hazard ratio, 1.03; 95% confidence interval, 0.96 to 1.10). Similarly, Kaplan-Meier survival curves were not significantly worse for recipients with national donors. Geographic distance did not independently predict 3-year mortality (hazard ratio, 0.95; 95% confidence interval, 0.89 to 1.01). CONCLUSIONS: With appropriate donor selection, moderately long geographic distance (average ischemic time < 6 hours) between the donor and recipient is not associated with the development of BOS or increased death after lung transplantation. By placing less emphasis on distance, more donors could potentially be used to expand the donor pool. Copyright Â
BACKGROUND: The shortage in organ donation is a major limiting factor for patients with end-stage lung disease. Expanding the donor pool would be beneficial. We investigated the importance of geographic distance between the donor and recipient and hypothesized that it would not be a critical determinant of outcomes after lung transplantation. METHODS: We retrospectively reviewed the United Network for Organ Sharing lung transplant database from 2000 to 2005 to allow sufficient time for bronchiolitis obliterans syndrome (BOS) development. Allograft recipients were stratified by geographic distance from their donors (local, regional, and national) and had yearly follow-up. The primary end points were the development of BOS and 1-year and 3-year mortality. Posttransplant outcomes were compared using a multivariable Cox proportional hazard model. Kaplan-Meier curves were compared by log-rank test. RESULTS: Of 6,055 allograft recipients, donors were local in 59%, regional in 19.3%, and national in 21.7%. BOS-free survival did not differ by geographic distance. Geographic distance did not independently predict BOS (hazard ratio, 1.03; 95% confidence interval, 0.96 to 1.10). Similarly, Kaplan-Meier survival curves were not significantly worse for recipients with national donors. Geographic distance did not independently predict 3-year mortality (hazard ratio, 0.95; 95% confidence interval, 0.89 to 1.01). CONCLUSIONS: With appropriate donor selection, moderately long geographic distance (average ischemic time < 6 hours) between the donor and recipient is not associated with the development of BOS or increased death after lung transplantation. By placing less emphasis on distance, more donors could potentially be used to expand the donor pool. Copyright Â
Authors: S Fischer; A Matte-Martyn; M De Perrot; T K Waddell; Y Sekine; M Hutcheon; S Keshavjee Journal: J Thorac Cardiovasc Surg Date: 2001-03 Impact factor: 5.209
Authors: Marc De Perrot; Thomas K Waddell; Yaron Shargall; Andrew F Pierre; Elie Fadel; Karl Uy; Cecilia Chaparro; Michael Hutcheon; Lianne G Singer; Shaf Keshavjee Journal: J Thorac Cardiovasc Surg Date: 2006-12-29 Impact factor: 5.209
Authors: S M Fiser; I L Kron; S M Long; A K Kaza; J A Kern; D C Cassada; D R Jones; M C Robbins; C G Tribble Journal: J Heart Lung Transplant Date: 2001-12 Impact factor: 10.247
Authors: Gabriel Thabut; Hervé Mal; Jacques Cerrina; Philippe Dartevelle; Claire Dromer; Jean-François Velly; Marc Stern; Philippe Loirat; Guy Lesèche; Michelle Bertocchi; Jean-François Mornex; Alain Haloun; Philippe Despins; Christophe Pison; Dominique Blin; Martine Reynaud-Gaubert Journal: Am J Respir Crit Care Med Date: 2005-01-21 Impact factor: 21.405
Authors: Jonathan C Yeung; Marcelo Cypel; Thomas K Waddell; Dirk van Raemdonck; Shaf Keshavjee Journal: Thorac Surg Clin Date: 2009-05 Impact factor: 1.750
Authors: Sara A Hennessy; Tjasa Hranjec; Brian R Swenson; Benjamin D Kozower; David R Jones; Gorav Ailawadi; Irving L Kron; Christine L Lau Journal: Ann Thorac Surg Date: 2010-05 Impact factor: 4.330
Authors: Hrishikesh S Kulkarni; Wida S Cherikh; Daniel C Chambers; Victoria C Garcia; Ramsey R Hachem; Daniel Kreisel; Varun Puri; Benjamin D Kozower; Derek E Byers; Chad A Witt; Jennifer Alexander-Brett; Patrick R Aguilar; Laneshia K Tague; Yuka Furuya; G Alec Patterson; Elbert P Trulock; Roger D Yusen Journal: J Heart Lung Transplant Date: 2018-09-25 Impact factor: 10.247
Authors: Darren E Stewart; Dallas W Wood; James B Alcorn; Erika D Lease; Michael Hayes; Brett Hauber; Rebecca E Goff Journal: BMC Med Inform Decis Mak Date: 2021-01-06 Impact factor: 2.796